SCHEMBL17059607

SCHEMBL17059607

C=CC(=O)Nc1cccc(NC(=O)Nc2nc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)ncc2Cl)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 1.00
JAK3 P52333 3/20 0.62
ALK Q9UM73 2/20 0.62
JAK2 O60674 2/20 0.62
FLT3 P36888 2/20 0.62
BLK P51451 2/20 0.62
BTK Q06187 2/20 0.62
ITK Q08881 2/20 0.62
PLK4 O00444 1/20 0.62
GAK O14976 1/20 0.62
NUAK1 O60285 1/20 0.62
BMX P51813 1/20 0.62
CTSC P53634 1/20 0.62
PTK2 Q05397 1/20 0.62
ERBB4 Q15303 1/20 0.62
DCLK3 Q9C098 1/20 0.62
NUAK2 Q9H093 1/20 0.62
EML4 Q9HC35 1/20 0.62
EIF2AK4 Q9P2K8 1/20 0.62
INSR P06213 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18778504 0.89 EGFR (0.83) EGFRJAK3ALKBTKGAK
SCHEMBL17059625 0.88 EGFR (1.00) EGFRJAK3
SCHEMBL2722635 0.88 EGFR (1.00) EGFRJAK3ALKJAK2FLT3
SCHEMBL12518488 0.87 EGFR (0.77) EGFRJAK3ALKJAK2FLT3
SCHEMBL17197331 0.87 EGFR (1.00) EGFRJAK3ALKBTKGAK
SCHEMBL10128129 0.83 EGFR (0.80) EGFRJAK3ALKJAK2FLT3
SCHEMBL10127856 0.83 EGFR (0.88) EGFRJAK3ALKJAK2FLT3
SCHEMBL4164770 0.83 EGFR (1.00) EGFRJAK3ALKJAK2FLT3
SCHEMBL9945446 0.82 EGFR (0.86) EGFRJAK3BTK
SCHEMBL28053865 0.82 EGFR (0.83) EGFRJAK3ALKJAK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015127873-A1 ARYLAMINO PYRAMIDINE COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS PREPARED THEREFROM 上海海雁医药科技有限公司 2015-09-03 WO disclosed